Naoki Inui Selected Research

Idiopathic Interstitial Pneumonias

1/2021	Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
7/2019	Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
1/2018	Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.
11/2011	Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF).
5/2008	Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia.
1/2008	Anti-endothelial cell antibodies in patients with interstitial lung diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoki Inui Research Topics

Disease

29	Idiopathic Pulmonary Fibrosis 01/2022 - 06/2005
28	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 09/2003
25	Neoplasms (Cancer) 02/2022 - 04/2003
22	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2008
14	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2003
14	Disease Progression 01/2022 - 03/2010
13	Asthma (Bronchial Asthma) 05/2022 - 08/2008
13	Chronic Obstructive Pulmonary Disease (COPD) 05/2022 - 12/2008
12	Nausea 10/2022 - 06/2014
11	Vomiting 10/2022 - 06/2014
11	Infections 02/2021 - 01/2005
10	Inflammation (Inflammations) 01/2022 - 09/2006
9	Adenocarcinoma of Lung 01/2022 - 01/2017
8	Sarcoidosis (Schaumann Disease) 11/2019 - 01/2005
7	Dermatomyositis (Dermatopolymyositis) 01/2021 - 01/2015
7	Vascular Diseases (Vascular Disease) 01/2016 - 01/2008
6	Idiopathic Interstitial Pneumonias 01/2021 - 01/2008
6	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 09/2002
5	Fibrosis (Cirrhosis) 01/2021 - 08/2010
5	Lung Diseases (Lung Disease) 02/2015 - 04/2008
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 08/2015
4	Pneumonia (Pneumonitis) 02/2020 - 09/2011
3	Death (Near-Death Experience) 04/2022 - 11/2020
3	Adenocarcinoma 01/2022 - 04/2003
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2021 - 01/2018
3	Pneumothorax 01/2021 - 01/2020
3	Pulmonary Hypertension 01/2021 - 11/2002
3	Rheumatoid Arthritis 07/2019 - 09/2008
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 04/2003
3	Neoplasm Metastasis (Metastasis) 12/2018 - 08/2015
2	Hemangioma (Angioma) 06/2022 - 01/2022
2	Body Weight (Weight, Body) 02/2022 - 12/2021
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2022 - 06/2015
2	Drug-Related Side Effects and Adverse Reactions 01/2022 - 01/2015
2	Obesity 01/2022 - 01/2019
2	Neutropenia 01/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

14	Carboplatin (JM8)FDA LinkGeneric 03/2022 - 09/2012
11	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2011
11	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 04/2012
10	Proteins (Proteins, Gene)FDA Link 07/2022 - 02/2008
9	Pharmaceutical PreparationsIBA 01/2022 - 06/2013
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 09/2006
8	AntiemeticsIBA 03/2022 - 06/2014
8	CollagenIBA 01/2016 - 01/2008
7	Dexamethasone (Maxidex)FDA LinkGeneric 06/2022 - 06/2014
7	ErbB Receptors (EGF Receptor)IBA 01/2021 - 08/2011
7	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 08/2011
6	Immune Checkpoint InhibitorsIBA 10/2021 - 05/2016
6	AntibodiesIBA 12/2016 - 01/2008
5	pirfenidoneIBA 07/2021 - 01/2014
5	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2016
5	EnzymesIBA 01/2021 - 09/2008
5	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 01/2014
5	Formoterol Fumarate (Oxis)FDA Link 01/2019 - 06/2012
5	Budesonide (Pulmicort)FDA LinkGeneric 01/2019 - 06/2012
5	Therapeutic UsesIBA 01/2015 - 05/2008
4	LigandsIBA 02/2022 - 06/2012
4	NivolumabIBA 02/2022 - 01/2019
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 07/2015
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 05/2008
4	ImmunosorbentsIBA 01/2021 - 09/2008
4	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2009
4	Mannose ReceptorIBA 02/2020 - 01/2018
4	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2019 - 01/2015
4	Phenobarbital (Luminal)FDA Link 01/2019 - 06/2013
4	VaccinesIBA 11/2015 - 10/2009
4	Tiotropium Bromide (Spiriva)FDA Link 02/2015 - 12/2008
3	Palonosetron (Aloxi)FDA Link 06/2022 - 12/2015
3	Bronchodilator Agents (Bronchodilators)IBA 05/2022 - 01/2015
3	Oxygen (Dioxygen)IBA 04/2022 - 03/2017
3	Olanzapine (Zyprexa)FDA Link 03/2022 - 01/2019
3	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 03/2022 - 07/2016
3	Neurokinin-1 Receptor AntagonistsIBA 03/2022 - 05/2017
3	LipidsIBA 01/2022 - 01/2005
3	AutoantibodiesIBA 01/2022 - 12/2016
3	PlatinumIBA 12/2021 - 08/2011
3	Peroxidase (Myeloperoxidase)IBA 01/2021 - 05/2008
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2018
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 09/2013
3	Interleukin-17 (Interleukin 17)IBA 10/2018 - 01/2014
3	CytokinesIBA 10/2018 - 09/2006
3	Aprepitant (Emend)FDA Link 09/2018 - 06/2014
3	Pemetrexed (MTA)FDA Link 06/2018 - 08/2013
3	Fluticasone (Cutivate)FDA LinkGeneric 01/2018 - 06/2012
3	AntigensIBA 01/2018 - 01/2005
3	Salmeterol Xinafoate (Serevent)FDA Link 01/2018 - 06/2012
3	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2015 - 05/2008
3	anti-endothelial cell antibodyIBA 12/2010 - 01/2008
2	fosaprepitant FDA Link 10/2022 - 06/2022
2	atezolizumabIBA 07/2022 - 01/2022
2	Propranolol (Inderal)FDA LinkGeneric 06/2022 - 01/2022
2	Muscarinic AntagonistsIBA 05/2022 - 02/2015
2	Serum AlbuminIBA 02/2022 - 12/2021
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2021 - 02/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2021 - 06/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 01/2014

Therapy/Procedure

48	Therapeutics 07/2022 - 06/2002
22	Drug Therapy (Chemotherapy) 10/2022 - 08/2011
2	Artificial Respiration (Mechanical Ventilation) 04/2022 - 06/2005
2	Aftercare (After-Treatment) 01/2022 - 06/2015